<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20131205015665N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-10</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of green tea extract on the postoperative pain following surgical removal of the impacted mandibular wisdom tooth</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of green tea extract on the postoperative pain following surgical removal of the impacted mandibular third molar</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>32</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49301</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: split-mouth design, Randomization description: pseudorandomization will be performed in this study. after considering an identification number from 1 to 32 for each patient; in patients with an odd ID number, green tea-impregnated gauze will be used on the right side and saline-impregnated gauze will be applied to the left side. in patients with an even ID number, green tea-impregnated gauze will be used on the left side and saline-impregnated gauze will be applied to the right side, Blinding description: for blinding the participants: they will not be aware of the exact location of application of the green tea-impregnated gauze after surgery
for blinding the care provider: the surgeon will not be aware of the exact location of application of the green tea-impregnated gauze after surgery and application of the gauze and patient's instruction will be performed by the researcher and in the absence of the surgeon.</study_design>
      <phase>N/A</phase>
      <hc_freetext>evaluation of the postoperative pain following application of the green tea-impregnated gauze after surgical extraction of the impacted mandibular third molar.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: All the surgeries will be performed by an experienced surgeon using the same protocol: the povidone-iodine solution will be applied to the surgical site; 2% lidocaine and 1:80,000 epinephrine (Iran, Tehran, Exir) will be used to block the inferior alveolar and long buccal nerves; a mucoperiosteal envelop flap will be created using a standard incision; if needed, bone removal, tooth sectioning, and bone recontouring will be performed with a low-speed hand-piece under sufficient sterile solution irrigation; following tooth removal the socket will be irrigated with 60 ml of saline; the flap will be sutured using 3–0 silk sutures. Green tea extract-impregnated sterile gauze will be used after removing the right or left tooth, according to the randomized order specified before and based on the patient's ID number. Both patients and surgeons will be blinded to the type of gauze. Iranian green tea will be purchased from the market (Iran, Mashhad, Zarghani company). For the preparation of hydroalcoholic extract, green tea will be powdered and 300 grams of the powder will be macerated by 1500 ml of ethanol 70% (v/v) for 72 hours. The extract will be then shaken, filtered and the solvent will be removed in a vacuum evaporator to obtain a semi-solid extract, and then it will be placed in an oven at 60°C for 72 hours. Patients will be instructed to take no painkiller or narcotics 12 hours before the procedure. As the surgery finished they will be given 10 Advalgine (Ibuprofen Lysine 400 mg) tablets and told to use them as the only medication for pain relief. They also will be instructed not to drink green tea beverages 48 hours after the operation. Respectively 6, 12, 24, and 48 hours after the end of the procedure by telephone contact, they will be asked about the presence and intensity of pain on the surgical site. On the third day after the operation, patients will be examined by the surgeon to note if they had experienced a dry socket. The decrease in the VAS pain scores as well as the number of analgesics used will be calculated for each patient. Intervention 2: Intervention group 2: All the surgeries will be performed by an experienced surgeon using the same protocol: the povidone-iodine solution will be applied to the surgical site; 2% lidocaine and 1:80,000 epinephrine (Iran, Tehran, Exir) will be used to block the inferior alveolar and long buccal nerves; a mucoperiosteal envelop flap will be created using a standard incision; if needed, bone removal, tooth sectioning, and bone recontouring will be performed with a low-speed hand-piece under sufficient sterile solution irrigation; following tooth removal the socket will be irrigated with 60 ml of saline; the flap will be sutured using 3–0 silk sutures. Green tea extract-impregnated sterile gauze will be used after removing the right or left tooth, according to the randomized order specified before and based on the patient's ID number. Both patients and surgeons will be blinded to the type of gauze. Patients will be instructed to take no painkiller or narcotics 12 hours before the procedure. As the surgery finished they will be given 10 Advalgine (Ibuprofen Lysine 400 mg) tablets and told to use them as the only medication for pain relief. They also will be instructed not to drink green tea beverages 48 hours after the operation. Respectively 6, 12, 24, and 48 hours after the end of the procedure by telephone contact, they will be asked about the presence and intensity of pain on the surgical site. On the third day after the operation, patients will be examined by the surgeon to note if they had experienced a dry socket. The decrease in the VAS pain scores as well as the number of analgesics used will be calculated for each patient.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is there is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Milad Etemadi Shalamzari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of oral and maxillofacial surgery, dentistry faculty, Isfahan university of medical sciences, Hezar-jerib st., Isfahan, Iran.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 5581</telephone>
        <email>etemadi@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Milad Etemadi Shalamzari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of oral and maxillofacial surgery, dentistry faculty, Isfahan university of medical sciences, Hezar-jerib st., Isfahan, Iran.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 5581</telephone>
        <email>etemadi@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having bilateral impacted mandibular third molar with the same difficulty based on the spatial direction of the teeth (mesioangular) on preoperative panoramic radiography
Having bilateral impacted mandibular third molar with the same difficulty based on the depth of impaction (Pell &amp; Gregory classifications/type B) on preoperative panoramic radiography
Having bilateral impacted mandibular third molar with the same difficulty based on the relationship with the anterior border of the ramus (class 1) on preoperative panoramic radiography</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>having allergy to green tea products
being younger than 18 years old or having more than 30 years of age
receiving other drugs like antibiotics, analgesics, and herbal therapy for pain/ infection in the last 30 days
presence of any kind of lesion (benign or malignant) in the site of surgery before surgery
pregnancy and/or lactation
systemic health problems
presence or history of  pain in the maxillofacial region like temporomandibular joint disorder (TMD) or myofascial pain and dysfunction syndrome (MPDS) before surgery
presence of pulpitis
drug addiction (methamphetamine, ephedrine, or cocaine)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.18</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other acute postprocedural pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: All the surgeries will be performed by an experienced surgeon using the same protocol: the povidone-iodine solution will be applied to the surgical site; 2% lidocaine and 1:80,000 epinephrine (Iran, Tehran, Exir) will be used to block the inferior alveolar and long buccal nerves; a mucoperiosteal envelop flap will be created using a standard incision; if needed, bone removal, tooth sectioning, and bone recontouring will be performed with a low-speed hand-piece under sufficient sterile solution irrigation; following tooth removal the socket will be irrigated with 60 ml of saline; the flap will be sutured using 3–0 silk sutures. Green tea extract-impregnated sterile gauze will be used after removing the right or left tooth, according to the randomized order specified before and based on the patient's ID number. Both patients and surgeons will be blinded to the type of gauze. Iranian green tea will be purchased from the market (Iran, Mashhad, Zarghani company). For the preparation of hydroalcoholic extract, green tea will be powdered and 300 grams of the powder will be macerated by 1500 ml of ethanol 70% (v/v) for 72 hours. The extract will be then shaken, filtered and the solvent will be removed in a vacuum evaporator to obtain a semi-solid extract, and then it will be placed in an oven at 60°C for 72 hours. Patients will be instructed to take no painkiller or narcotics 12 hours before the procedure. As the surgery finished they will be given 10 Advalgine (Ibuprofen Lysine 400 mg) tablets and told to use them as the only medication for pain relief. They also will be instructed not to drink green tea beverages 48 hours after the operation. Respectively 6, 12, 24, and 48 hours after the end of the procedure by telephone contact, they will be asked about the presence and intensity of pain on the surgical site. On the third day after the operation, patients will be examined by the surgeon to note if they had experienced a dry socket. The decrease in the VAS pain scores as well as the number of analgesics used will be calculated for each patient.</i_keyword>
      <i_keyword>Intervention group 2: All the surgeries will be performed by an experienced surgeon using the same protocol: the povidone-iodine solution will be applied to the surgical site; 2% lidocaine and 1:80,000 epinephrine (Iran, Tehran, Exir) will be used to block the inferior alveolar and long buccal nerves; a mucoperiosteal envelop flap will be created using a standard incision; if needed, bone removal, tooth sectioning, and bone recontouring will be performed with a low-speed hand-piece under sufficient sterile solution irrigation; following tooth removal the socket will be irrigated with 60 ml of saline; the flap will be sutured using 3–0 silk sutures. Green tea extract-impregnated sterile gauze will be used after removing the right or left tooth, according to the randomized order specified before and based on the patient's ID number. Both patients and surgeons will be blinded to the type of gauze. Patients will be instructed to take no painkiller or narcotics 12 hours before the procedure. As the surgery finished they will be given 10 Advalgine (Ibuprofen Lysine 400 mg) tablets and told to use them as the only medication for pain relief. They also will be instructed not to drink green tea beverages 48 hours after the operation. Respectively 6, 12, 24, and 48 hours after the end of the procedure by telephone contact, they will be asked about the presence and intensity of pain on the surgical site. On the third day after the operation, patients will be examined by the surgeon to note if they had experienced a dry socket. The decrease in the VAS pain scores as well as the number of analgesics used will be calculated for each patient.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of the pain based on Visual analogue scale (VAS). Timepoint: evaluation of the severity of the pain 6, 12, 24, and 48 hours after surgery. Method of measurement: using Visual analogue scale (VAS).</prim_outcome>
      <prim_outcome>Number of analgesics (ibuprofen) used after surgery. Timepoint: 6, 12, 24,and 48 hours after surgery. Method of measurement: asking the patient.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-15</approval_date>
        <contact_name>Ethics committee of Isfahan university of medical sciences</contact_name>
        <contact_address>oral and maxillofacial surgery department, dentistry faculty, Isfahan university of medical sciences,Hezar-jerib st., Isfahan, Iran. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
